March 15, 2016 / 1:18 PM / 2 years ago

BRIEF-Aralez resubmits NDA for Yosprala to FDA

March 15 (Reuters) - Aralez Pharmaceuticals Inc

* Aralez resubmits to FDA New Drug Application for Yosprala

* FDA is expected to issue Aralez an acknowledgment letter within 30 days of resubmission

* If accepted, acknowledgement would also include a new Prescription Drug User Fee Act date Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below